Clinical Utility of Thiopurine S -Methyltransferase Genotyping

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.4, Iss.1, 2004-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacogenomics of Thiopurine S-methyltransferase

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Significance of Thiopurine S-Methyltransferase Gene Polymorphisms

Current Pharmacogenomics, Vol. 5, Iss. 2, 2007-06 ,pp. : 103-115

Bentham Science Publishers

Access to resources Recommend Favorite

Utility of Assessing Thiopurine S-methyltransferase Polymorphisms Before Azathioprine Therapy

Current Drug Metabolism, Vol. 13, Iss. 9, 2012-11 ,pp. : 1277-1293

Bentham Science Publishers

Access to resources Recommend Favorite

The thiopurine S-methyltransferase gene locus – implications for clinical pharmacogenomics

By McLeod Howard L Siva Chokkalingam

Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. : 89-98

Future Medicine

Access to resources Recommend Favorite

Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe

By van den Akker-van Marle M Elske Gurwitz David Detmar Symone B Enzing Christine M Hopkins Michael M Gutierrez de Mesa Emma Ibarreta Dolores

Pharmacogenomics, Vol. 7, Iss. 5, 2006-07 ,pp. : 783-792

Future Medicine

Access to resources Recommend Favorite